The Claim
Thyroid follicular cells in Hashimoto thyroiditis express PD-L1 on both the cell membrane and cytoplasm, while thyroid follicular cells in nonautoimmune controls express PD-L1 only in the cytoplasm, indicating a disease-specific alteration in the PD-1/PD-L1 checkpoint pathway within the thyroid microenvironment.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In Hashimoto thyroiditis, thyroid cells display PD-L1 protein on their surface and inside the cell, whereas in healthy thyroid tissue, PD-L1 is found only inside the cell.
See the scientific wording
Thyroid follicular cells in Hashimoto thyroiditis exhibit PD-L1 expression on both the cell membrane and cytoplasm, whereas in nonautoimmune controls, PD-L1 is expressed only in the cytoplasm, suggesting a disease-specific alteration in the PD-1/PD-L1 checkpoint pathway within the thyroid microenvironment.
In Hashimoto thyroiditis, immune cells in the thyroid release a signal that causes thyroid cells to move a braking protein to their surface. This protein locks onto a receptor on overactive immune cells, turning them off and preventing them from destroying the thyroid. At the same time, a different type of immune cell becomes permanently activated and also uses this same braking system to calm down other immune cells, keeping the attack slow and ongoing.
What the research says
1 studyIn people with Hashimoto’s, thyroid cells show a protein called PD-L1 on their surface and inside, but in healthy thyroids, it’s only inside. This might be the thyroid’s way of trying to calm down the immune system’s attack.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.